'Two weeks after the last dose, antibodies to P. falciparum circumsporozoite protein and PfSPZ were higher in protected versus unprotected vaccinees. A three-dose regimen of PfSPZ Vaccine demonstrated safety and efficacy against malaria infection in malaria-experienced adults.'

#Immunology #Malaria #InfetionImmunity #vaccine
https://www.science.org/doi/full/10.1126/scitranslmed.abj3776?af=R